Prophages at the Interface of Antibiotic Tolerance, Persistence and Antibiotic Resistance: Evidence, Mechanisms and Therapeutic Limits
Drug Resistance Updates · 2026-11 · 101505
DOI: 10.1016/j.drup.2026.101505 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2026-11. Verfasst von Fazlurrahman Khan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Program of Marine and Fisheries Sciences and Convergent Technology, Pukyong National University, Busan 48513, Republic of Korea; Oc…. Die Arbeit nennt 125 Literaturangaben. Gefördert von: Korea Ministry of Science and ICT.
Abstract (Originalsprache)
Prophages are widespread in bacterial genomes, and several experimental systems show that they change how bacteria survive antibiotics. Using the consensus definitions of Balaban and colleagues, this review sorts the primary evidence by the endpoint actually measured: resistance defined by the minimum inhibitory concentration (MIC), tolerance (killing kinetics), persistence (biphasic killing), resuscitation (single-cell regrowth), and stress or biofilm survival. These endpoints are not treated as interchangeable. Effects depend on strain, prophage, antibiotic, and endpoint. In Escherichia coli, deleting nine cryptic prophages leaves persister formation unchanged but accelerates resuscitation. In Salmonella enterica serovar Typhimurium, ciprofloxacin-induced Gifsy-1 lysis lowers persister survival, and TisB raises persister numbers largely by limiting that induction. In methicillin-resistant Staphylococcus aureus, φSA169 increases survival at a single 24 h vancomycin time point without changing the MIC, which is a survival difference at one time point and does not demonstrate tolerance or persistence. Unverified prophages can confound persistence assays. Prophage genomes rarely encode resistance genes; a Pseudomonas aeruginosa clinical collection showed only infrequent prophage-resistance associations, and transduction can nonetheless move resistance determinants. Whether prophage-associated survival under antibiotic exposure promotes or restricts the evolution of resistance is an open hypothesis, supported by one species, one antibiotic, and a preprint, and a serial-passaging design to test it is outlined. Gut and probiotic prophages are abundant and inducible, but persistence data for them are lacking. Therapeutic approaches are separated into those acting on resident prophages, temperate phage-antibiotic synergy, and related but distinct strategies. Evidence that any prophage-directed intervention eliminates persisters in infection models is currently lacking. A minimum reporting checklist for future studies is provided.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interdisciplinary Program of Marine and Fisheries Sciences and Convergent Technology, Pukyong National University, Busan 48513, Republic of Korea; Ocean and Fisheries Development International Cooperation Institute, Puk…
- Marine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan 48513, Republic of Korea; Research Center for Marine Integrated Bionics Technology…
- Interdisciplinary Program of Marine and Fisheries Sciences and Convergent Technology, Pukyong National University, Busan 48513, Republic of Korea.
- Ocean and Fisheries Development International Cooperation Institute, Pukyong National University, Busan 48513, Republic of Korea; Marine Integrated Biomedical Technology Center, The National Key Research Institutes in U…
Förderung
- Korea Ministry of Science and ICT
Zitieren
APA
Khan, F., Tabassum, N., Javaid, A., Kim, T. H., & Kim, Y. M. (2026). Prophages at the Interface of Antibiotic Tolerance, Persistence and Antibiotic Resistance: Evidence, Mechanisms and Therapeutic Limits. Drug Resistance Updates, 101505. https://doi.org/10.1016/j.drup.2026.101505
Vancouver
Khan F, Tabassum N, Javaid A, Kim TH, Kim YM. Prophages at the Interface of Antibiotic Tolerance, Persistence and Antibiotic Resistance: Evidence, Mechanisms and Therapeutic Limits. Drug Resistance Updates. 2026:101505. doi:10.1016/j.drup.2026.101505
BibTeX
@article{Khan2026,
author = {Khan, Fazlurrahman and Tabassum, Nazia and Javaid, Aqib and Kim, Tae-Hee and Kim, Young-Mog},
title = {Prophages at the Interface of Antibiotic Tolerance, Persistence and Antibiotic Resistance: Evidence, Mechanisms and Therapeutic Limits},
journal = {Drug Resistance Updates},
year = {2026},
pages = {101505},
doi = {10.1016/j.drup.2026.101505}
}
EUVIMED